NON-PHARMACOLOGICAL CORRECTION EFFICACY OF CLINICAL COURSE OF NON-EROSIVE FORMS OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH HYPERTENSION COMBINED WITH CHRONIC ISCHEMIC HEART DISEASE
DOI:
https://doi.org/10.11603/2415-8798.2016.3.6963Keywords:
hypertension, coronary heart disease, NERD, non-pharmacological correction, non-cardiac chest pain.Abstract
The aim was to determine the effect of non-drug therapies for a NERD patients with hypertension combined with chronic ischemic coronary artery disease. to compare the effects of non-pharmacological correction, the clinical symptoms of NERD, depending on the degree of adherence to treatment in patients with hypertension combined with chronic ischemic heart disease. For this purpose it was examined in the dynamics of 37 patients with hypertension combined with chronic ischemic heart disease on the background of NERD. As a result of observation, they were divided into groups: 20 (54.05 %) patients with high adherence to treatment, and 17 (45.95 %) with low adherence to treatment. Among the selected patients was 21 (56.75%) females and 16 (43.25 %) men. All patients underwent were performed clinical tests, eCG, endoscopy, carried out a test according to the questionnaire GerdQ, and visual analogue scale (VAS) determine the degree of severity of pain in the chest. the study found that patients with high adherence to treatment demonstrated significantly better results in the correction GeRD symptoms as opposed to patients with low adherence to treatment. This group of patients had more frequent symptoms of heartburn daily and showed a greater percentage of cases greater severity of cardiac chest pain. thus, it confirmed the need for maximum stimulation of the patients for execution of recommendations on non-pharmacological correction, when GERD, including patients with hypertension combined with chronic ischemic heart disease on the background of NERD.References
Alekseyeva O. P. Koronarnyy sindrom KH– odna iz vnepishchevodnykh masok gastroezofageal'noy reflyuksnoy bolezni ? / O. P. Alekseyeva, I. V. Dolbin // Meditsina neotlozhnykh sostoyaniy.– 2009 .– № 1. – S. 23–25.
Babak M. O. Gastroyezofageal'na reflyuksna khvoroba v poêdnanní z ozhirínnyam: klíníko-patogenetichní osoblivostí, yepídemíologíchniy analíz ta prognozuvannya perebígu : avtoref. dis. na zdobuttya nauk. stupenya doktora med. nauk : spets. 14.01.02 «Vnutríshní khvorobi» / M. O. Babak.–Lugans'k, 2011.– 27 s.
Ostroglyad A. V. Pershiy dosvíd vivchennya yepídemíologíí̈ gastroyezofageal'noí̈ reflyuksnoí̈ khvorobi v Ukraí̈ní / A. V. Ostroglyad // Suchasna gastroyenterol. – 2006. – № 1. – S. 30–32.
Kharchenko N. V. Gastoyezofageal'na reflyuksna khvoroba. Adaptovana klíníchna nastanova, zasnovana na dokazakh / N. V. Kharchenko, O. YA. Babak, P. D. Fomín ta ín. – Kií̈v, 2013. – 31 s.
Kharchenko N. V. Díêtologíya / N. V. Kharchenko, G. A. Anokhína. — K. : MERIDIAN, 2012. — 527s.
Chung S. J. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups / S. J. Chung, D. Kim, M. J. Park et al. // Gut. – 2008. – Vol. 57. – P. 1360–1365.
Jones R. Management of gastroesophageal reflux disease: the primary care strategy/R. Jones // Yale J Biol Med. –1999.–Vol. 72.– P.203–209.
KeungCh. The management of gastro-oesophageal reflux disease /Ch. Keung//Aust. Prescr.– 2016. – Vol. 39. – P.6–10.
Kubo Ai Dietary guideline adherence for gastroesophageal reflux disease /Ai Kubo, G. Block, P. Charles, P. Buffler at al. // BMC Gastroenterol. – 2014. – Vol. 14. – P.144.
Lesley BNon-pharmacological intervention for gastro-oesophageal reflux disease in primary care / B.Lesley,C. Dibley, R. Jones //Br. J. Gen. Pract.– 2010. – Vol. 60. – P.e459–e465.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)